{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T22:46:07Z","timestamp":1770417967381,"version":"3.49.0"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,6,5]]},"DOI":"10.1097\/cm9.0000000000000248","type":"journal-article","created":{"date-parts":[[2019,4,5]],"date-time":"2019-04-05T18:44:28Z","timestamp":1554489868000},"page":"1261-1263","source":"Crossref","is-referenced-by-count":4,"title":["Macrolides for treatment of chronic obstructive pulmonary disease"],"prefix":"10.1097","volume":"132","author":[{"given":"Xue-Jiao","family":"Sun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-Yi","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-1-20210129","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1183\/09031936.00136712","article-title":"Long-term macrolide treatment for chronic respiratory disease","volume":"42","author":"Spagnolo","year":"2013","journal-title":"Eur Respir J"},{"key":"R2-1-20210129","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.mayocp.2014.09.006","article-title":"Non-anti-infective effects of antimicrobials and their clinical applications: a review","volume":"90","author":"Sadarangani","year":"2015","journal-title":"Mayo Clin Proc"},{"key":"R3-1-20210129","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.pupt.2009.03.002","article-title":"Effects of prolonged use of azithromycin in patients with cystic fibrosis: a meta-analysis","volume":"22","author":"Florescu","year":"2009","journal-title":"Pulm Pharmacol Ther"},{"key":"R4-1-20210129","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1001\/jama.290.13.1749","article-title":"Azithromycin in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa: a randomized controlled trial","volume":"290","author":"Saiman","year":"2003","journal-title":"JAMA"},{"key":"R5-1-20210129","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1056\/NEJMoa0909883","article-title":"Susceptibility to exacerbation in chronic obstructive pulmonary disease","volume":"16","author":"Hurst","year":"2010","journal-title":"N Engl J Med"},{"key":"R6-1-20210129","first-page":"751982","article-title":"The role of macrolides in noncystic fibrosis bronchiectasis","volume":"2011","author":"Figueiredo Bde","year":"2011","journal-title":"Pulm Med"},{"key":"R7-1-20210129","first-page":"242","article-title":"Long-term efficacy of macrolide treatment in idiopathic pulmonary fibrosis: a retrospective analysis","volume":"33","author":"Kuse","year":"2016","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"R8-1-20210129","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.rmed.2004.06.009","article-title":"The effect of oral clarithromycin on health status and sputum bacteriology in stable COPD","volume":"99","author":"Banerjee","year":"2005","journal-title":"Respir Med"},{"key":"R9-1-20210129","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1164\/rccm.200801-145OC","article-title":"Long-term erythromycin therapy is associated with decreased chronic obstructive pulmonary disease exacerbations","volume":"178","author":"Seemungal","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"R10-1-20210129","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1056\/NEJMoa1104623","article-title":"Azithromycin for prevention of exacerbations of COPD","volume":"365","author":"Albert","year":"2011","journal-title":"N Engl J Med"},{"key":"R11-1-20210129","doi-asserted-by":"crossref","first-page":"3813","DOI":"10.2147\/COPD.S181246","article-title":"Long-term macrolide treatment for the prevention of acute exacerbations in COPD: a systemic review and meta-analysis","volume":"13","author":"Cui","year":"2018","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"R12-1-20210129","first-page":"449","article-title":"Long-term azithromycin therapy in patients with severe COPD and repeated exacerbations","volume":"6","author":"Pomares","year":"2016","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"R13-1-20210129","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1159\/000321374","article-title":"Effect of 6 months of erythromycin treatment on inflammatory cells in induced sputum and exacerbations in chronic obstructive pulmonary disease","volume":"80","author":"He","year":"2010","journal-title":"Respiration"},{"key":"R14-1-20210129","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1164\/rccm.201402-0207OC","article-title":"Predictors of chronic obstructive pulmonary disease exacerbation reduction in response to daily azithromycin therapy","volume":"189","author":"Han","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"R15-1-20210129","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1136\/eb-2013-101711","article-title":"Long-term antibiotic therapy reduces exacerbation frequency in patients with COPD but it remains unclear which patients to target","volume":"19","author":"Allinson","year":"2014","journal-title":"Evid Based Med"},{"key":"R16-1-20210129","first-page":"833","article-title":"Effects of mucolytic agents and macrolides in the treatment of COPD","volume":"74","author":"Yamaya","year":"2016","journal-title":"Nihon Rinsho"},{"key":"R17-1-20210129","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1183\/09031936.00128008","article-title":"Systemic manifestations and comorbidities of COPD","volume":"33","author":"Barnes","year":"2009","journal-title":"Eur Respir J"},{"key":"R18-1-20210129","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1128\/CMR.00078-09","article-title":"Mechanisms of action and clinical application of macrolides as immunomodulatory medications","volume":"23","author":"Kanoh","year":"2010","journal-title":"Clin Microbiol Rev"},{"key":"R19-1-20210129","doi-asserted-by":"crossref","first-page":"L139","DOI":"10.1152\/ajplung.00292.2014","article-title":"Combination of erythromycin and dexamethasone improves corticosteroid sensitivity induced by cigarette smoke extract through inhibition of PI3K-\u03b4\/Akt pathway and increased GR expression","volume":"309","author":"Sun","year":"2015","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"R20-1-20210129","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1016\/j.intimp.2011.06.010","article-title":"The expression of Foxp3 and ROR gamma t in lung tissues from normal smokers and chronic obstructive pulmonary disease patients","volume":"11","author":"Chu","year":"2011","journal-title":"Int Immunopharmacol"},{"key":"R21-1-20210129","doi-asserted-by":"crossref","first-page":"350727","DOI":"10.1155\/2013\/350727","article-title":"Persistence of Th17\/Tc17 cell expression upon smoking cessation in mice with cigarette smoke-induced emphysema","volume":"2013","author":"Duan","year":"2013","journal-title":"Clin Dev Immunol"},{"key":"R22-1-20210129","doi-asserted-by":"crossref","first-page":"410232","DOI":"10.1155\/2012\/410232","article-title":"Erythromycin enhances CD4+Foxp3+ regulatory T-cell responses in a rat model of smoke-induced lung inflammation","volume":"2012","author":"Bai","year":"2012","journal-title":"Mediators Inflamm"},{"key":"R23-1-20210129","doi-asserted-by":"crossref","first-page":"1700214","DOI":"10.1183\/13993003.00214-2017","article-title":"Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report: GOLD executive summary","volume":"49","author":"Voqelmeier","year":"2017","journal-title":"Eur Respir J"},{"key":"R24-1-20210129","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1056\/NEJMp1302726","article-title":"Cardiovascular risks with azithromycin and other antibacterial drugs","volume":"368","author":"Mosholder","year":"2013","journal-title":"N Engl J Med"},{"key":"R25-1-20210129","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1164\/rccm.201402-0385CI","article-title":"Macrolide antibiotics and the risk of cardiac arrhythmias","volume":"189","author":"Albert","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"R26-1-20210129","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S2213-2600(14)70019-0","article-title":"Azithromycin maintenance treatment in patients with frequent exacerbations of chronic obstructive pulmonary disease (COLUMBUS): a randomised, double-blind, placebo-controlled trial","volume":"2","author":"Uzun","year":"2014","journal-title":"Lancet Respir Med"},{"key":"R27-1-20210129","doi-asserted-by":"crossref","first-page":"1362e1","DOI":"10.1016\/j.amjmed.2015.07.032","article-title":"Azithromycin for prevention of COPD exacerbations: the good, bad, and ugly","volume":"128","author":"Taylor","year":"2015","journal-title":"Am J Med"}],"container-title":["Chinese Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00029330-201906050-00001","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,30]],"date-time":"2021-01-30T12:23:09Z","timestamp":1612009389000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00029330-201906050-00001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,5]]},"references-count":27,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/cm9.0000000000000248","relation":{},"ISSN":["0366-6999"],"issn-type":[{"value":"0366-6999","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6,5]]}}}